EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Obesity management medications: The way forward

Matthias Blüher iD

Science · 05.11.2026 · 394 (6824) · 626-632

DOI: 10.1126/science.aej1120 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Science, erschienen am 05.11.2026. Verfasst von Matthias Blüher. Beteiligte Einrichtung: Helmholtz Institute for Metabolic, Obesity and Vascular Research (HI-MAG) of the Helmholtz Zentrum München at the University of Leipzig and Universit…. Hauptthemen laut MEDLINE: Anti-Obesity Agents, Obesity, Glucagon-Like Peptide-1 Receptor Agonists. Die Arbeit nennt 53 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Obesity is now widely recognized as a chronic progressive condition. The altered biological mechanisms that cause obesity frequently require long-term treatment, including pharmacotherapies or bariatric surgery. In recent decades, the pathophysiology of obesity has been understood to an extent that obesity management medication (OMM) discovery could be rationally pursued. Advances in defining the regulation of food intake and energy expenditure by molecular communication from peripheral organs to the brain led to the development of OMMs that appear capable of safely achieving scalable and sustained body weight loss. However, side effects, heterogeneous treatment responses, long-term metabolic adaptations, adherence, and other factors may limit the use of existing OMMs and justify the development of additional medications to improve the health of people living with obesity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Obesity AgentsObesityGlucagon-Like Peptide-1 Receptor AgonistsHumansEnergy MetabolismWeight LossAdipose TissueDrug Development

Substanzen

Anti-Obesity AgentsGlucagon-Like Peptide-1 Receptor Agonists

Autor:innen und Institutionen

  • Helmholtz Institute for Metabolic, Obesity and Vascular Research (HI-MAG) of the Helmholtz Zentrum München at the University of Leipzig and University Hospital Leipzig, Leipzig, Germany.
  • Medical Department III-Endocrinology, Nephrology, Rheumatology, University of Leipzig Medical Center, Leipzig, Germany.
  • Leipzig Center of Metabolism (LeiCeM), University of Leipzig, Leipzig, Germany.

ORCID-Profile: Matthias Blüher

Zitieren

APA

Blüher, M. (2026). Obesity management medications: The way forward. Science, 394(6824), 626-632. https://doi.org/10.1126/science.aej1120

Vancouver

Blüher M. Obesity management medications: The way forward. Science. 2026;394(6824):626-632. doi:10.1126/science.aej1120

BibTeX
@article{Blher2026,
  author = {Blüher, Matthias},
  title = {Obesity management medications: The way forward},
  journal = {Science},
  year = {2026},
  volume = {394},
  number = {6824},
  pages = {626--632},
  doi = {10.1126/science.aej1120}
}
Kostenlos starten →